Insider Trading & Ownership - Lim Bryant David

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Lim Bryant David
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-05-24
Purchase
2023-05-25
4:07 pm
Prelude Therapeutics IncPRLDLim Bryant David
Chief Legal Officer, Corp Sec.
2,400$5.39$12,9362,400
(Direct)
View
2021-03-25
Sale
2021-03-29
4:09 pm
IDERA PHARMACEUTICALS INC.IDRALim Bryant David
SVP AND GENERAL COUNSEL
7,630$1.3601$10,37830,434
(Direct)
View
2021-01-12
Sale
2021-01-12
7:08 pm
IDERA PHARMACEUTICALS INC.IDRALim Bryant David
SVP and General Counsel
1,711$4.2091$7,20289,064
(Direct)
View
2021-01-05
Sale
2021-01-11
8:15 pm
IDERA PHARMACEUTICALS INC.IDRALim Bryant David
SVP and General Counsel
1,465$3.9058$5,72239,775
(Direct)
View
2020-01-08
Sale(A)
2020-01-14
6:10 pm
IDERA PHARMACEUTICALS INC.IDRALim Bryant David
SVP and General Counsel
1,603$1.7804$2,85421,240
(Direct)
View
2020-01-07
Sale
2020-01-10
08:07 am
IDERA PHARMACEUTICALS INC.IDRALim Bryant David
SVP and General Counsel
1,603$1.7804$2,85421,240
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-01
Option Award
2024-03-04
6:07 pm
N/A
2034-02-28
Prelude Therapeutics IncPRLDLim Bryant David
Chief Legal Officer, Corp Sec.
150,000$0150,000
(Direct)
View
2023-03-01
Option Award
2023-03-02
4:06 pm
N/A
2033-02-28
Prelude Therapeutics IncPRLDLim Bryant David
Chief Legal Officer, Corp Sec.
250,000$0250,000
(Direct)
View
2023-01-20
Option Award
2023-02-02
8:08 pm
N/A
2033-01-20
Aceragen Inc.ACGNLim Bryant David
SVP AND GENERAL COUNSEL
25,400$025,400
(Direct)
View
2023-01-06
Option Award
2023-01-10
9:17 pm
N/A
N/A
IDERA PHARMACEUTICALS INC.IDRALim Bryant David
SVP AND GENERAL COUNSEL
399,218$0309,695
(Direct)
View
2023-01-06
Tax Withholding
2023-01-10
9:17 pm
N/A
N/A
IDERA PHARMACEUTICALS INC.IDRALim Bryant David
SVP AND GENERAL COUNSEL
119,957$0.7099309,695
(Direct)
View
2022-07-06
Option Award
2022-07-07
5:33 pm
N/A
2032-07-06
IDERA PHARMACEUTICALS INC.IDRALim Bryant David
SVP AND GENERAL COUNSEL
66,500$066,500
(Direct)
View
2022-04-01
Option Award
2022-04-04
5:44 pm
N/A
2032-04-01
IDERA PHARMACEUTICALS INC.IDRALim Bryant David
SVP AND GENERAL COUNSEL
41,500$041,500
(Direct)
View
2022-01-24
Option Award
2022-01-26
8:43 pm
N/A
2032-01-24
IDERA PHARMACEUTICALS INC.IDRALim Bryant David
SVP AND GENERAL COUNSEL
25,000$025,000
(Direct)
View
2021-07-08
Option Award
2021-07-12
4:05 pm
N/A
2031-07-08
IDERA PHARMACEUTICALS INC.IDRALim Bryant David
SVP AND GENERAL COUNSEL
66,500$066,500
(Direct)
View
2021-01-08
Option Award
2021-01-12
7:08 pm
N/A
2031-01-08
IDERA PHARMACEUTICALS INC.IDRALim Bryant David
SVP and General Counsel
51,000$089,064
(Direct)
View
2020-07-21
Option Award
2020-07-23
4:37 pm
N/A
2030-07-21
IDERA PHARMACEUTICALS INC.IDRALim Bryant David
SVP and General Counsel
50,000$050,000
(Direct)
View
2020-01-10
Option Award
2020-01-14
6:56 pm
N/A
2030-01-10
IDERA PHARMACEUTICALS INC.IDRALim Bryant David
SVP and General Counsel
70,000$091,240
(Direct)
View
2019-07-09
Option Award
2019-07-11
5:17 pm
N/A
2029-07-09
IDERA PHARMACEUTICALS INC.IDRALim Bryant David
SVP and General Counsel
45,500$045,500
(Direct)
View
(A) Indicate amendment filing.